Profiles people listing in a scrolling container.
  1. Home
  2. People

Ludwig Gutmann, MD

Emeritus Professor of Neurology

Current Positions

  • Clinical Professor of Neurology
  • Specialty: Neuromuscular Disease

Education

  • BA, Princeton University, Princeton, New Jersey, United States
  • MD, College of Physicians and Surgeons, Columbia University, New York, New York, United States
  • MD, University of Mainz (honorary), Mainz, Germany

Research Interests

  • COMET: A phase 3 randomized, multicenter, multinational, double-blinded study comparing the efficacy and safety
  • Muscular Dystrophy Association Block Grant
  • A Study of Elevated Creatine Kinase Levels and Cramp Frequency in Patients With Amyotrophic Lateral Sclerosis
  • A Two Year open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson’s Disease Patients
  • An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Sub-Cutaneous Injections of Apomorphine in the Treatment of “Off” Episodes in Patients With “On-Off” or “Wearing-Off” Effects Associated With Late-Stage Parkinson’s Disease
  • A Treatment Protocol Using Myotrophin (human mecasermin [recombinant DNA Origin]) Injection in Patients With Amyotrophic Lateral Sclerosis
  • A Prospective, Randomized, Placebo-Controlled, Parallel Groups Study of the Continued Efficacy and Safety of Subcutaneous Injections of Apomorphine in the Treatment of “Off” Episodes in Patients with “On-Off” or “Wearing Off” Effects Associated with Late-Stage Parkinson’s Disease after Apomorphine Use for at Least a Three Month Duration
  • Multicenter Open-label Trial of Rilutek (Riluzole) 50 Mg Bid in Treatment of Amyotrophic Lateral Sclerosis (ALS) 1995-1996. Sub-Investigator
  • Clinical Trial of IGF-1 in Patients with Amyotrophic Lateral Sclerosis (ALS)
  • A Survey Of Patient Preference for Apomorphine Subcutaneous Injections Using the Injector Pen or Ampule/Syringe in the treatment of “Off” Episodes in Patients with Late-Stage Parkinson’s Disease Who Have Treat “Off” Episodes with Subcutaneous Injections of Apomorphine for at Least Three Months

Licenses & Certifications

  • Iowa Medical License, Iowa
  • American Board of Psychiatry and Neurology-certification in Neuromuscular Medicine
  • Maryland Medical License, Maryland
  • American Board of Psychiatry and Neurology-certification in Clinical Neurophysiology
  • West Virginia Medical License, West Virginia

Selected Publications